ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,390Medicare Part D Prescriptions Filled, Including Refills

Rank: 492 out of 3734

$565K Total Retail Price of All Prescriptions

Rank: 551 out of 3734

404 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,862 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 388 350 1 7
SIMVASTATIN 374 307 2 1
WARFARIN SODIUM 365 333 3 10
LEVOTHYROXINE SODIUM 346 308 4 2
LISINOPRIL 298 288 5 3
METOPROLOL TARTRATE 293 270 6 6
AMLODIPINE BESYLATE 284 262 7 5
POLYETHYLENE GLYCOL 3350 212 174 8 53
CITALOPRAM HBR 197 186 9 16
OMEPRAZOLE 172 134 10 4
LANTUS 158 105 11 54
OXYCODONE-ACETAMINOPHEN 151 137 S2 12 51
GABAPENTIN 149 111 13 17
PRAVASTATIN SODIUM 148 146 14 15
HYDROCODONE-ACETAMINOPHEN 147 130 S3 15 12
METFORMIN HCL 143 138 16 8
GLIMEPIRIDE 140 140 17 37
FAMOTIDINE 139 112 18 60
TAMSULOSIN HCL 138 130 19 29
ZOLPIDEM TARTRATE 131 75 20 24
MIRTAZAPINE 120 114 21 45
METOPROLOL SUCCINATE 97 88 22 14
CARVEDILOL 94 81 23 30
NYSTOP 87 81 24 187
ATENOLOL 86 82 25 13
CLOPIDOGREL 84 79 26 23
LOSARTAN POTASSIUM 84 81 26 21
TRAZODONE HCL 83 81 28 49
NOVOLOG 81 56 29 112
ISOSORBIDE MONONITRATE ER 81 61 29 34
ALBUTEROL SULFATE 79 64 31 128
KLOR-CON M20 78 75 32 48
ALLOPURINOL 76 65 33 33
FENTANYL 74 29 S2 34 65
DIVALPROEX SODIUM 68 39 35 99
PREDNISONE 64 60 36 42
PANTOPRAZOLE SODIUM 62 62 37 22
TORSEMIDE 62 55 37 160
CYMBALTA 60 59 39 67
DONEPEZIL HCL 60 60 39 25
TRAMADOL HCL 59 51 41 20
SERTRALINE HCL 59 48 41 18
PAROXETINE HCL 57 47 43 59
PLAVIX 54 50 44 39
DIOVAN 52 52 45 31
CIPROFLOXACIN HCL 51 44 46 77
RISPERIDONE 51 37 46 62
FENOFIBRATE 50 46 48 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.